These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9718276)

  • 61. Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation.
    Johnson KW; Nelson DL; Dieckman DK; Wainscott DB; Lucaites VL; Audia JE; Owton WM; Phebus LA
    Cephalalgia; 2003 Mar; 23(2):117-23. PubMed ID: 12603368
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
    Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
    J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
    [TBL] [Abstract][Full Text] [Related]  

  • 63. SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity.
    Selkirk JV; Scott C; Ho M; Burton MJ; Watson J; Gaster LM; Collin L; Jones BJ; Middlemiss DN; Price GW
    Br J Pharmacol; 1998 Sep; 125(1):202-8. PubMed ID: 9776361
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [35S]GTPgammaS binding at the human dopamine D4 receptor variants hD4.2, hD4.4 and hD4.7 following stimulation by dopamine, epinephrine and norepinephrine.
    Czermak C; Lehofer M; Liebmann PM; Traynor J
    Eur J Pharmacol; 2006 Feb; 531(1-3):20-4. PubMed ID: 16423344
    [TBL] [Abstract][Full Text] [Related]  

  • 65. mu-Opioid agonist-stimulated [35S]GTPgammaS binding in guinea pig hypothalamus: effects of estrogen.
    Cunningham MJ; Fang Y; Selley DE; Kelly MJ
    Brain Res; 1998 Apr; 791(1-2):341-6. PubMed ID: 9593984
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry.
    Newman-Tancredi A; Audinot V; Moreira C; Verrièle L; Millan MJ
    Mol Pharmacol; 2000 Nov; 58(5):1042-9. PubMed ID: 11040052
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interaction of 5-HT1B/D ligands with recombinant h 5-HT1A receptors: intrinsic activity and modulation by G-protein activation state.
    Pauwels PJ; Palmier C; Dupuis DS; Colpaert FC
    Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):490-9. PubMed ID: 9650800
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs.
    Johnson KW; Schaus JM; Durkin MM; Audia JE; Kaldor SW; Flaugh ME; Adham N; Zgombick JM; Cohen ML; Branchek TA; Phebus LA
    Neuroreport; 1997 Jul; 8(9-10):2237-40. PubMed ID: 9243618
    [TBL] [Abstract][Full Text] [Related]  

  • 69. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
    Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Methods for the evaluation of drug action at the human melatonin receptor subtypes.
    Nonno R; Fraschini F; Stankov BM
    Biol Signals Recept; 1999; 8(1-2):32-40. PubMed ID: 10085460
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
    Odagaki Y; Toyoshima R
    Eur J Pharmacol; 2005 Oct; 521(1-3):49-58. PubMed ID: 16182280
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
    Pullar IA; Boot JR; Broadmore RJ; Eyre TA; Cooper J; Sanger GJ; Wedley S; Mitchell SN
    Eur J Pharmacol; 2004 Jun; 493(1-3):85-93. PubMed ID: 15189767
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Characterization of endomorphin-1 and -2 on [35S]GTPgammaS binding in the mouse spinal cord.
    Narita M; Mizoguchi H; Oji GS; Tseng EL; Suganuma C; Nagase H; Tseng LF
    Eur J Pharmacol; 1998 Jun; 351(3):383-7. PubMed ID: 9721032
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Measurement of agonist-stimulated [35S]GTPgammaS binding to assess total G-protein and Galpha-subtype-specific activation by G-protein-coupled receptors.
    Dowling MR; Nahorski SR; Challiss RA
    Methods Mol Biol; 2004; 259():197-206. PubMed ID: 15250494
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The pre- and postjunctional activity of CP-122,288, a conformationally restricted analogue of sumatriptan.
    Beattie DT; Connor HE
    Eur J Pharmacol; 1995 Apr; 276(3):271-6. PubMed ID: 7601213
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.
    Odagaki Y; Kinoshita M; Toyoshima R
    Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):175-85. PubMed ID: 21443596
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Subtype-specific stimulation of [35S]GTPgammaS binding by recombinant alpha2-adrenoceptors.
    Peltonen JM; Pihlavisto M; Scheinin M
    Eur J Pharmacol; 1998 Aug; 355(2-3):275-9. PubMed ID: 9760042
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mechanisms of agonist action at D2 dopamine receptors.
    Roberts DJ; Lin H; Strange PG
    Mol Pharmacol; 2004 Dec; 66(6):1573-9. PubMed ID: 15340043
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injury.
    Garrett SM; Whitaker RM; Beeson CC; Schnellmann RG
    J Pharmacol Exp Ther; 2014 Aug; 350(2):257-64. PubMed ID: 24849926
    [TBL] [Abstract][Full Text] [Related]  

  • 80. N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy.
    Xu YC; Johnson KW; Phebus LA; Cohen M; Nelson DL; Schenck K; Walker CD; Fritz JE; Kaldor SW; LeTourneau ME; Murff RE; Zgombick JM; Calligaro DO; Audia JE; Schaus JM
    J Med Chem; 2001 Nov; 44(24):4031-4. PubMed ID: 11708905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.